Novo Nordisk said on Thursday its experimental obesity drug CagriSema significantly reduced blood pressure in a late-stage ...
Novo Nordisk expects global sales to decline by low-single-digit percentage in 2026 after the drugmaker unveiled a deal on ...
U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...
U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...
Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...
Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...
The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...
Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera ...
The revised bids are the latest unusual twist in the fight between big drugmakers over drug developer Metsera.
Danish company is battling with Pfizer for US biotech as they seek edge in growing market for weight-loss drugs ...
A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...
Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results